http://www.arcade-project.org Vaccines: Part 1 A history of policy context, impacts and approaches Professor Melissa Leach - Brighton, UK All course materials are published by the ARCADE Projects under

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director

Global health and vaccination: TB & beyond Dr Mary Moran Executive Director mmoran@policycures.org Outline About Policy Cures 3 reasons to focus on vaccine innovation Where are we today? The pipeline Where

Perspectives on Ensuring Access to Vaccines in Lower Income Countries

Perspectives on Ensuring Access to Vaccines in Lower Income Countries Greg Widmyer Deputy Director, Vaccine Delivery Foundation Merieux January 20, 2015 Bill & Melinda Gates Foundation BMGF GLOBAL PROGRAMS

VACCINE MARKETS OVERVIEW SESSION

VACCINE MARKETS OVERVIEW SESSION Robyn Iqbal Program Officer, Vaccine Delivery Market Dynamics UNICEF SD Manufacturers Meeting Copenhagen October 8, 2014 DRAFT Bill & Melinda Gates Foundation DISCUSSION

Overview. Vaccine innovation With people, for people: The (A) citizens' view. Vaccine impact in perspective. Vaccine research in perspective

Overview Vaccine innovation With people, for people: The (A) citizens' view Disclaimer about the citizen Ending AIDS? A history lesson A way forward hopefully Mitchell Warren Executive Director, AVAC 12

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION.

In the Name of God, the Compassionate, the Merciful Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION on the FIRST EMIRATES INTERNATIONAL CONFERENCE ON VACCINATION Dubai,

Texas Immunization Coverage Levels TVFC Conference-Permian Basin April 20, 2016

Texas Immunization Coverage Levels TVFC Conference-Permian Basin April 20, 2016 www.immunizetexas.com Impact of Immunization Programs The routine childhood immunization program* of 4.3 million children

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

Message from Dr Samlee Plianbangchang Regional Director, WHO South-East Asia At the Regional Review Meeting on Immunization 19-23 July 2010 WHO/SEARO, New Delhi Regional Review Meeting on Immunization

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing

Partnerships for Vaccines Forum

October 30, 2018 Partnerships for Vaccines Forum PATH s 40+ years of transformative innovation Steve Davis President & CEO, PATH Photos: PATH/Aaron Joel Santos, PATH/Gabe Bienczycki, PATH/Gabe Bienczycki

Gavi s strategic framework 22 June 2016

Gavi s 2016 2020 strategic framework 22 June 2016 Gavi 2000-2015 Gavi 3.0 Gavi 2.0 250 million children immunised Gavi 1.0 90m children immunised 200 million children immunised 2000 2005 2006 2010 2011

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe Progress Toward Rubella Elimination and CRS Prevention in Europe February 8-10, 2012; Rome, Italy

Establishing a second-year-of-life (2YL) healthy child visit

Establishing a second-year-of-life (2YL) healthy child visit Dr Rudi Eggers Presentation to the Global Vaccines and Immunization Research Forum Sandton, 15 March 2016 Session Objectives Provide an overview

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper

How to present the European Vaccine Action Plan (EVAP)

How to present the European Vaccine Action Plan 2015-2020 () HOW TO USE THIS DOCUMENT By adopting the European Vaccine Action Plan 2015-2020 () in September 2014, all Member States of the WHO European

Global Rotavirus Surveillance Network

Global Rotavirus Surveillance Network Dr. Adam L. Cohen World Health Organization 7 September 2016 1 TITLE from VIEW and SLIDE MASTER 22 September 2016 Vaccine-preventable disease surveillance Active vs.

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we

Deadly Imbalance: Social vs Medical Value of Preventative Vaccines

Deadly Imbalance: Social vs Medical Value of Preventative Vaccines Donald P. Francis, MD, DSc Global Solutions for Infectious Diseases Brisbane, CA, USA Public Health Goal Decrease or eliminate disease

Vaccine Decision-Making

Key Points Vaccine Decision-Making * Decisions on introducing new vaccines have long-term implications for immunization costs as well as logistics systems and service delivery. The choice of vaccine presentation

Report on MCSP Support for the Polio Switch in April 2016

Report on MCSP Support for the Polio Switch in April 2016 www.mcsprogram.org Report date: September 1, 2016 This report is made possible by the generous support of the American people through the United

Japan's Role in Global Health and Human Security

Japan's Role in Global Health and Human Security Prof.Keizo TAKEMI Senior Fellow, Japan Center for Interantional Exchange, Research Fellow, Harvard School of Public Health Professor, Tokai University Why

WHO Update Tania Cernuschi & Patrick Lydon

IVB/EPI/STF WHO Update Tania Cernuschi & Patrick Lydon Session 2 UNICEF Vaccine Industry Consultation 5-6 October 2017 IVB/EPI/STF 1 The Big Picture WHO s Immunization Department Supply, Technologies and

VACCINE FACT BOOK 2012

VACCINE FACT BOOK 2012 Preface Prevention is better than cure is a proverb in many other languages as well. This idea is central to the development of vaccines, which have transformed human health since

GAVI Role in IPV Introductions

GAVI Role in IPV Introductions Melissa Malhame 12 th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities Geneva, Switzerland, 10 GAVI vaccine support Currently supported

WHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases

National Center for Immunization & Respiratory Diseases WHY WE RE HERE Melinda Wharton, MD, MPH Director, Immunization Services Division AIM Leadership Conference February 8, 2017 Vaccines save lives.

Saving Vaccines in the Americas: A Framework for Vaccine Safety Training

Saving Vaccines in the Americas: A Framework for Vaccine Safety Training Elizabeth K. Lutz, MPH Candidate Colorado School of Public Health Edwin J. Asturias, MD Director for Latin America, Center for Global

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE Aurélia Nguyen Tuesday 20 January 2015, Veyrier-du-Lac, France www.gavi.org AGENDA Market

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

On the Horizon for Consideration: Biomedical Advances in HIV Prevention Francisco Ruiz, MS Senior Manager, National Alliance of State and Territorial AIDS Directors New Jersey Governor's Advisory Council

Innovation, Access and Delivery for Universal Health Coverage

A side event at the UHC Forum Co-hosted by UNDP and the GHIT Fund Tokyo, Japan 12 December 2017 Innovation, Access and Delivery for Universal Health Coverage From Innovation & Inequality, a UNDP-supported

Overall presentation of IVR Strategy

Annex 3 Overall presentation of IVR Strategy Presentation to the IVR Advisory committee (IVAC) April 2007 Outline Why does WHO invest in Research & Development? What is the Initiative for Vaccine Research

Access to vaccination in GAVI countries and at global level

Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for

Global Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters

Global Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters UNICEF Vaccine Industry Consultation Copenhagen 5 October 2017 Outline Status & directions

Communicating about HPV vaccination: Lessons learned from physicians and parents

Communicating about HPV vaccination: Lessons learned from physicians and parents Melissa B. Gilkey, PhD Assistant Professor of Population Medicine Harvard Medical School & Harvard Pilgrim Health Care Institute

Adolescent Health programme and its contribution to the success of vaccination in Finland

Adolescent Health programme and its contribution to the success of vaccination in Finland Kaarina Järvenpää Kaarina Järvenpää 1 Childhood vaccination schedule In Finland from 1.1.2005 (Vaccinator s Handbook

What is Implementation Science? Bryan J. Weiner, Ph.D. University of North Carolina at Chapel Hill

What is Implementation Science? Bryan J. Weiner, Ph.D. University of North Carolina at Chapel Hill Roadmap How do domestic and global perspectives on IS differ? How is IS different from: Process evaluation?

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

http://www.paho.org/provac Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative Cara Bess Janusz Immunization, PAHO 1 st Regional Dengue Symposium 3-4 November

The Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative

The Value of Product Development Partnerships in Vaccine Innovation Hansi J. Dean International AIDS Vaccine Initiative The Product Development Partnership Model A non-profit partnership of public and

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share

Telemedicine: Connecting Behavioral Health and Medical Care

Telemedicine: Connecting Behavioral Health and Medical Care Lawrence S. Brown, Jr., MD, MPH, FASAM CEO, START Treatment & Recovery Centers Clinical Associate Professor of Medicine and Health Care and Policy

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated 2.13.19) Contact: Brian Massa, Senior Manager for Global Health Advocacy, Shot@Life (bmassa@unfoundation.org) USAID Global Health Programs (GHP) and State

1. The World Bank-GAVI Partnership and the Purpose of the Review

1. The World Bank-GAVI Partnership and the Purpose of the Review 1.1 The new World Bank Group strategy makes a strong case for an expanded World Bank Group role in global and regional dialogue and collective

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

Report 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria Kano, Nigeria 12-13 July 2006 Executive Summary The 10 th Expert Review Committee (ERC) met in Kano on 12-13 July

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS

Vaccine Innovation and Adult Immunization Landscape

Vaccine Innovation and Adult Immunization Landscape National Adult and Influenza Immunization Summit, May 12-14, 2015 Phyllis Arthur Senior Director Vaccines, Immunotherapeutics & Diagnostics Policy parthur@bio.org

Maternal Immunization: Unique considerations of public health value of vaccines given to pregnant women

Maternal Immunization: Unique considerations of public health value of vaccines given to pregnant women Estimating the full public health value of vaccines Kathleen M. Neuzil, MD, MPH Professor of Medicine

Evaluating HPV Vaccine Delivery Strategies in Vietnam

Evaluating HPV Vaccine Delivery Strategies in Vietnam PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding

CGD Brief. Vaccines for Development Owen Barder * The case for vaccines

CGD Brief Owen Barder * Immunization is one of the best ways to improve health in developing countries. While the importance of vaccines is increasingly well-understood, significant challenges inhibit

Challenges of building a new vaccine delivery platform for LMICs

Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland What has been

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives August 2013 The challenge Abdul, a young boy in Sierra Leone, was one of the lucky ones. He was severely

GAVI S VACCINE INVESTMENT STRATEGY

GAVI S VACCINE INVESTMENT STRATEGY Judith Kallenberg, Head of Policy PDVAC 22 June 2017, Geneva Reach every child www.gavi.org Gavi finances vaccines and immunisation through three routes ($9 Billion in

Global Pulse Oximetry Project

3.3 Introduction of new health technologies: lessons learned Over the past twenty years there have been a number of comprehensive public health projects which illustrate important lessons regarding the

Why GAVI Needs to Do More To Ensure Lower Vaccine Prices And How It Could Be Done

Why GAVI Needs to Do More To Ensure Lower Vaccine Prices And How It Could Be Done Vaccines are widely considered a highly cost-effective public health intervention. Médecins Sans Frontières (MSF) is actively

Vaccine Trends Social Barometer

Vaccine Trends Social Barometer Geographic Activity for 7/1/13-7/31/13 July 2013 Monthly Activity Summary Unique Alerts Curated 929 Total Alerts (Including Duplicate Reports) 1899 Report Vaccine Sentiment

Modern Drug House.

+91-8048941768 Modern Drug House https://www.moderndrughouse.in/ We are one of the leading suppliers and traders of a wide range of Vaccine and Pharmaceutical Products. Owing to its effectiveness, purity

Contents. Part One Vaccine Use. Acknowledgments

Contents Foreword Acknowledgments xiii xv Part One Vaccine Use Chapter 1 Introduction 1 To Vaccinate or Not to Vaccinate? 2 Not the Last Word 3 Permission Granted 4 Your Right to Know 4 The Goals of This

HPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION

National Center for Immunization & Respiratory Diseases HPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION Melinda Wharton, MD, MPH Director, Immunization Services Division Mississippi Primary Health

Responding to Vaccine Safety Events

Responding to Vaccine Safety Events Karen Midthun, MD, Deputy Director Center for Biologics Evaluation and Research, FDA ICDRA Conference Berne, Switzerland September 19, 2008 1 Vision for CBER INNOVATIVE

Viral Hepatitis Prevention Board CREATIVE FINANCING SOLUTIONS TO SCALE UP PREVENTION & TREATMENT OF HBV/HCV

Viral Hepatitis Prevention Board CREATIVE FINANCING SOLUTIONS TO SCALE UP PREVENTION & TREATMENT OF HBV/HCV vhpt-booklet-edits.indd 1 PUBLIC HEALTH TARGET WHO TARGETS TO CONTROL VIRAL HEPATITIS BY 2030

Module 2: Vaccines and drugs: similarities and differences

Module 2: Vaccines and drugs: similarities and differences Vaccine PV Fellowship WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance Accra, Ghana 7 th 18 th September 2015 Learning

High-Technology Route To Virus Vaccines READ ONLINE

High-Technology Route To Virus Vaccines READ ONLINE If you are searching for a book High-Technology Route to Virus Vaccines in pdf form, in that case you come on to the loyal website. We presented the

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention Dr. Carol Levin PATH Video transcript is located below each slide. Cost-effectiveness, Affordability, and Financing of Cervical

Taking vaccine effectiveness into public health decision making: The ProVac Example

http://www.paho.org/provac Taking vaccine effectiveness into public health decision making: The ProVac Example Evaluating dengue effectiveness workshop June 12 th, 2014 Washington, DC Cara Bess Janusz

IMPORTANCE OF VACCINE PREVENTABLE DISEASE INCIDENCE. Bradford D. Gessner, MD Agence de Médecine Preventive

IMPORTANCE OF VACCINE PREVENTABLE DISEASE INCIDENCE Bradford D. Gessner, MD Agence de Médecine Preventive Vaccine Launches 2013 2 Disease burden has been consistently mentioned by policymakers in countries

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as

DOWNLOAD OR READ : THE UNIVERSAL VACCINE PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : THE UNIVERSAL VACCINE PDF EBOOK EPUB MOBI Page 1 Page 2 the universal vaccine the universal vaccine pdf the universal vaccine Influenza vaccines, also known as flu shots or flu jabs,

Mass Vaccination Using a Microneedle Patch Sebastien Henry, MS, MBA

Mass Vaccination Using a Microneedle Patch Sebastien Henry, MS, MBA Laboratory of Mark Prausnitz, PhD Georgia Institute of Technology Atlanta, GA, USA Microneedle patch Vaccine vial Microneedles Conventional

Vaccine Introduction & Uptake Timing Benchmark Project

Vaccine Introduction & Uptake Timing Benchmark Project Lois Privor-Dumm Managing Director Policy, Advocacy & Communications Team Lead International Vaccine Access Center Johns Hopkins Bloomberg School

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

Let s talk about protection Childhood Vaccination. Flipbook to support conversations with parents and caregivers

Let s talk about protection Childhood Vaccination Flipbook to support conversations with parents and caregivers F Let s talk about protection Childhood Vaccination Flipbook to support conversations with

Access to Vaccines: Where are we, Why are we there, Where do we need to get to? Martin Friede Initiative for Vaccine Research

Access to Vaccines: Where are we, Why are we there, Where do we need to get to? Martin Friede Initiative for Vaccine Research Vaccines work, but vaccine preventable diseases are still a significant cause

2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS

2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS Background The Global Polio Eradication Initiative (GPEI) is financed through a range of public and private donations. The Financial Resource

Lessons of Disease Eradication Efforts for Invasive Mussel Control. Jim Koopman MD MPH, Professor Emeritus

Lessons of Disease Eradication Efforts for Invasive Mussel Control Jim Koopman MD MPH, Professor Emeritus Talk Organization Antecedents to Smallpox Eradication philosophy Yellow fever and Malaria Smallpox,

Global Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva

Global Immunization Overview Thomas Cherian Expanded Programme on Immunization WHO, Geneva Global U5 Mortality: Role of Vaccine Preventable Diseases (2008 data) 8.8 million under five deaths Other 20%

UNICEF and the 2030 agenda for Sustainable Development; Focus on Health

UNICEF and the 2030 agenda for Sustainable Development; Focus on Health Dr Claudia Vivas Torrealba, Health Specialist cvivas@unicef.org Health Section. Program Division Sep 2016 UNICEF Health Strategy

The protective power of vaccination

The protective power of vaccination Life is a health journey; help protect it against life-threatening infectious diseases. Smallpox used to kill millions of people worldwide¹. Polio paralyzed and killed

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives The challenge Abdul, Sierra Leone Abdul, a young boy in Sierra Leone, was one of the lucky ones. In June

Monitoring and Evaluation IN ACTION! Duff Gillespie

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

Gavi s private sector engagement approach

Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY

SELF TESTING FOR HIV, A GAME CHANGER, REALLY?

SELF TESTING FOR HIV, A GAME CHANGER, REALLY? NITIKA PANT PAI, MD, MPH, PhD McGill University and McGill University Health Centre Montreal, Quebec, Canada Assistant Professor, Clinical Epidemiology & Infectious

From development to delivery: Decision-making for the introduction of a new vaccine

From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines

Accelerating action towards elimination of cervical cancer: Social Media Messaging Toolkit

Accelerating action towards elimination of cervical cancer: Social Media Messaging Toolkit 1. Objectives The objectives of this social media toolkit are to support dissemination of the cervical cancer

Dr. Collins Tabu 24 th April 2018 Nairobi, Kenya

Dr. Collins Tabu 24 th April 2018 Nairobi, Kenya Immunization in the developing world Every year, millions of children in poor countries die from preventable diseases because they do not have access to

Hilleman Laboratories

Hilleman Laboratories If I had to name a person who has done more for the benefit of human health, with less recognition than anyone else, it would be Maurice Hilleman. Maurice should be recognized as

Ex post evaluation Tanzania

Ex post evaluation Tanzania Sector: Health, family planning, HIV/AIDS (12250) Project: Promotion of national vaccination programme in cooperation with GAVI Alliance, Phase I and II (BMZ no. 2011 66 586

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

Choosing an Alternative Vaccine Schedule

Choosing an Alternative Vaccine Schedule Paul A. Offit Division of Infectious Diseases Children s Hospital of Philadelphia Perelman School of Medicine The University of Pennsylvania General Information

Global Health Policy: Vaccines

Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY

Reasons for vaccine acceptance: parents and girls perspectives

HPV vaccine acceptability Vaccine acceptability was assessed differently depending on the target group (policymakers, health workers, parents, eligible girls). Key research questions for the policymaker

DESIGNING AND IMPLEMENTING HIGH-QUALITY VOLUNTARY FAMILY PLANNING PROGRAMS

POLICY BRIEF DESIGNING AND IMPLEMENTING HIGH-QUALITY VOLUNTARY FAMILY PLANNING PROGRAMS WWW.POPCOUNCIL.ORG 1 The Population Council confronts critical health and development issues from stopping the spread

Effective Date: Key Features: Provides coverage for the 64 preventive and wellness services needed to provide Minimum Essential Coverage.

Effective Date: Jan 01, 2015 Key Features: Provides coverage for the 64 preventive and wellness services needed to provide Minimum Essential Coverage. First dollar coverage no deductibles or co-insurance.

Innovative Finance: the power of innovation to save lives

Innovative Finance: the power of innovation to save lives GAVI s mission is to save children s lives and protect people s health by increasing access to immunisation in poor countries. To that end, the

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC

2007 ACIP Recommendations for Influenza Vaccine Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC National Influenza Vaccine Summit April 19, 2007 Recommendation Changes for Influenza Vaccination:

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

Fact sheet Poliomyelitis WHO Media centre ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM Media centre Poliomyelitis Fact sheet Updated April 2016 Key

1 We need to invest more in vaccines

We need to invest more in vaccines Chapter at a glance Vaccines represent the best hope for large, rapid and affordable improvements in health in the developing world. Vaccines developed for affluent countries

How would a comprehensive surveillance look like (with ball park costing?)

1 How would a comprehensive surveillance look like (with ball park costing?) 2-3 Nov 2017, London, UK Zainul Abedin Khan, WHO HQ POL Polio surveillance and the (bumpy) road to transition 2 Tool Goals Overall

Priority Area: 1 Access to Oral Health Care

If you are unable to attend one of the CHARTING THE COURSE: Developing the Roadmap to Advance Oral Health in New Hampshire meetings but would like to inform the Coalition of activities and services provided

Human H5N1 and Pandemic Vaccines Practicalities of Production: A perspective from Industry

Human H5N1 and Pandemic Vaccines Practicalities of Production: A perspective from Industry Luc Hessel M.D. Pandemic Influenza Working Group European Vaccine Manufacturers 4th Joint EC/ECDC/WHO Workshop

The ORION Medical Journal 2004 Jan;17:

Zinc treatment for childhood diarrhoea A new and innovative project of ICDDR,B: Centre for Health and Population Research Larson CP, Ernst R The ORION Medical Journal 2004 Jan;17:136-138 Introduction In

USAID Progress: The U.S. National Vaccine Plan of 1994

USAID Progress: The U.S. National Vaccine Plan of 1994 Ellyn Ogden Neal Brandes Angela Weaver Washington DC March 3, 2008 Objective 1.1/1.5 (New Vaccines) Support to GAVI for introduction of new vaccines